These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 10372611

  • 1. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J.
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clozapine reduces violence and persistent aggression in schizophrenia.
    Glazer WM, Dickson RA.
    J Clin Psychiatry; 1998; 59 Suppl 3():8-14. PubMed ID: 9541332
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI.
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [Abstract] [Full Text] [Related]

  • 7. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S, Stip E, Roy JY.
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM, Singh P, Shepherd CJ, Puthiryackal J.
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [Abstract] [Full Text] [Related]

  • 11. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM, Leucht S, Carpenter D, Docherty JP, Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.
    J Clin Psychiatry; 2003 Apr; 64 Suppl 12():5-19. PubMed ID: 14640142
    [Abstract] [Full Text] [Related]

  • 12. Predictors of violent behavior among acute psychiatric patients: clinical study.
    Amore M, Menchetti M, Tonti C, Scarlatti F, Lundgren E, Esposito W, Berardi D.
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):247-55. PubMed ID: 18588583
    [Abstract] [Full Text] [Related]

  • 13. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
    Krakowski MI, Czobor P, Nolan KA.
    J Clin Psychopharmacol; 2008 Oct; 28(5):485-93. PubMed ID: 18794642
    [Abstract] [Full Text] [Related]

  • 14. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN, Cummings JL, Abrams BI, DeMet EM, Katz LS, Costa JF.
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [Abstract] [Full Text] [Related]

  • 15. Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy.
    Buckley P, Thompson P, Way L, Meltzer HY.
    Am J Psychiatry; 1994 Mar; 151(3):385-9. PubMed ID: 8109646
    [Abstract] [Full Text] [Related]

  • 16. A national study of violent behavior in persons with schizophrenia.
    Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, Rosenheck RA, Stroup TS, McEvoy JP, Lieberman JA.
    Arch Gen Psychiatry; 2006 May; 63(5):490-9. PubMed ID: 16651506
    [Abstract] [Full Text] [Related]

  • 17. Clozapine use in a forensic population in a New South Wales prison hospital.
    Martin A, O'Driscoll C, Samuels A.
    Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.